CapsoVision CV
NASDAQ CV
$6.44 -0.25 (-3.74%)
As of: Sep 30, 2026 · 3:12 PM EDT

CapsoVision (CV) Operating Leases (2024 - 2026)

Updated

CapsoVision (CV) recorded Operating Leases of $245,000 in Q2 2026, down 64.3% from $687,000 a year earlier.

Analysis

CapsoVision (CV) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, CapsoVision reported Operating Leases of $477,000, down 46.2% from FY2024.

  • Across earlier years, Operating Leases came in at $887,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 CapsoVision 334.72 Mn 334.72 Mn 1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 245,000.00
Dec 31, 2025 477,000.00
Sep 30, 2025 584,000.00
Jun 30, 2025 687,000.00
Dec 31, 2024 887,000.00
API Access

CapsoVision Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CV&period=max&api_key=YOUR_API_KEY